SNBL USA to Host Upcoming Reproductive Toxicology Web Seminar

Everett, WA - October 22, 2007 - SNBL USA invites you to register for its Web Seminar launch event, "Reproductive and Developmental Risk Assessment in Nonhuman Primates (NHPs): Technical and Biological Considerations," scheduled to take place November 1, 2007 at 11:00 am (PST).

SNBL USA is the recognized leader in performing high quality reproductive and developmental toxicity studies in NHPs with noted industry expertise. "Drawing on the wealth of our experience and expertise, we are excited to present to a broader audience around the subject of Reproductive Toxicity Testing in NHPs," said Brian Baker, DABT, SNBL USA Executive Director of Preclinical Services.

Dr. Norbert Makori, one of the few leading industry experts in the field of reproductive toxicology, will present an overview of the following topics:

• When is a Pre- and Postnatal Development study required?
• Standard ICH/OECD designs for Pre- and Postnatal Development - timelines and what you REALLY need to know
• New trends: Combination Seg II/III Study Testing
• Do all biologics require NHP reproductive toxicity testing?
• Small molecule companies ask: Do we need to perform NHP repro studies?
• NHP source/origin and other species considerations

A dedicated Question & Answer session will follow the presentation. Dr. Makori along with Dr. Satoru Oneda, an internationally recognized industry expert with over 20 years of reproductive and developmental toxicology experience, will be available to answer attendees’ questions. If you would like to participate in this Web seminar please contact info@snblusa.com for more information.

About SNBL USA, Ltd.

SNBL USA, Ltd. is a preclinical CRO that specializes in nonhuman primate (NHP) and small animal research. Study programs range from regulatory toxicology to customized study designs and disease models. Specialized programs include reproductive toxicology, safety pharmacology, immunotoxicology and carcinogenicity. SNBL USA’s Laboratory Services division intelligently applies extensive experience, comprehensive scientific capabilities, and modern technology to bring outstanding support to all client research. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information call 425.407.0121 or visit www.snblusa.com.